Type IV collagen stimulates pancreatic cancer cell proliferation, migration, and inhibits apoptosis through an autocrine loop

BMC Cancer

Daniel Öhlund¹  Oskar Franklin¹  Erik Lundberg¹  Christina Lundin¹  Malin Sund¹ 

[1] Department of Surgical and Perioperative Sciences, Umeå University, SE-901 85, Umeå, Sweden

关键词: Autocrine loop;    Integrin receptors;    Basement membrane;    Pancreatic cancer;    Type IV collagen;   

Others  :  1079836
DOI  :  10.1186/1471-2407-13-154

 received in 2012-09-18, accepted in 2013-03-19,  发布年份 2013

【 摘 要 】

Background

Pancreatic cancer shows a highly aggressive and infiltrative growth pattern and is characterized by an abundant tumor stroma known to interact with the cancer cells, and to influence tumor growth and drug resistance. Cancer cells actively take part in the production of extracellular matrix proteins, which then become deposited into the tumor stroma. Type IV collagen, an important component of the basement membrane, is highly expressed by pancreatic cancer cells both in vivo and in vitro. In this study, the cellular effects of type IV collagen produced by the cancer cells were characterized.

Methods

The expression of type IV collagen and its integrin receptors were examined in vivo in human pancreatic cancer tissue. The cellular effects of type IV collagen were studied in pancreatic cancer cell lines by reducing type IV collagen expression through RNA interference and by functional receptor blocking of integrins and their binding-sites on the type IV collagen molecule.

Results

We show that type IV collagen is expressed close to the cancer cells in vivo, forming basement membrane like structures on the cancer cell surface that colocalize with the integrin receptors. Furthermore, the interaction between type IV collagen produced by the cancer cell, and integrins on the surface of the cancer cells, are important for continuous cancer cell growth, maintenance of a migratory phenotype, and for avoiding apoptosis.

Conclusion

We show that type IV collagen provides essential cell survival signals to the pancreatic cancer cells through an autocrine loop.

【 授权许可】

   
2013 Öhlund et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ: Cancer statistics, 2008. CA Cancer J Clin 2008, 58:71-96.
• [2]Bilimoria KY, Bentrem DJ, Ko CY, Ritchey J, Stewart AK, Winchester DP, Talamonti MS: Validation of the 6th edition AJCC pancreatic cancer staging system: report from the national cancer database. Cancer 2007, 110:738-744.
• [3]Goldstein D, Carroll S, Apte M, Keogh G: Modern management of pancreatic carcinoma. Intern Med J 2004, 34:475-481.
• [4]Bachem MG, Zhou S, Buck K, Schneiderhan W, Siech M: Pancreatic stellate cells–role in pancreas cancer. Langenbecks Arch Surg 2008, 393:891-900.
• [5]Omary MB, Lugea A, Lowe AW, Pandol SJ: The pancreatic stellate cell: a star on the rise in pancreatic diseases. J Clin Invest 2007, 117:50-59.
• [6]Armstrong T, Packham G, Murphy LB, Bateman AC, Conti JA, Fine DR, Johnson CD, Benyon RC, Iredale JP: Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma. Clin Cancer Res 2004, 10:7427-7437.
• [7]Grzesiak JJ, Ho JC, Moossa AR, Bouvet M: The integrin-extracellular matrix axis in pancreatic cancer. Pancreas 2007, 35:293-301.
• [8]Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, Honess D, Madhu B, Goldgraben MA, Caldwell ME, Allard D: Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 2009, 324:1457-1461.
• [9]Lee CS, Montebello J, Georgiou T, Rode J: Distribution of type IV collagen in pancreatic adenocarcinoma and chronic pancreatitis. Int J Exp Pathol 1994, 75:79-83.
• [10]Linder S, Castanos-Velez E, von Rosen A, Biberfeld P: Immunohistochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma. Hepatogastroenterology 2001, 48:1321-1327.
• [11]Ohlund D, Lundin C, Ardnor B, Oman M, Naredi P, Sund M: Type IV collagen is a tumour stroma-derived biomarker for pancreas cancer. Br J Cancer 2009, 101:91-97.
• [12]Khoshnoodi J, Pedchenko V, Hudson BG: Mammalian collagen IV. Microsc Res Tech 2008, 71:357-370.
• [13]Lohr M, Trautmann B, Gottler M, Peters S, Zauner I, Maillet B, Kloppel G: Human ductal adenocarcinomas of the pancreas express extracellular matrix proteins. Br J Cancer 1994, 69:144-151.
• [14]Grzesiak JJ, Bouvet M: Determination of the ligand-binding specificities of the alpha2beta1 and alpha1beta1 integrins in a novel 3-dimensional in vitro model of pancreatic cancer. Pancreas 2007, 34:220-228.
• [15]Lohr M, Trautmann B, Gottler M, Peters S, Zauner I, Maier A, Kloppel G, Liebe S, Kreuser ED: Expression and function of receptors for extracellular matrix proteins in human ductal adenocarcinomas of the pancreas. Pancreas 1996, 12:248-259.
• [16]Sawai H, Okada Y, Funahashi H, Takahashi H, Matsuo Y, Yasuda A, Ochi N, Takeyama H, Manabe T: Basement membrane proteins play an important role in the invasive processes of human pancreatic cancer cells. J Surg Res 2008, 144:117-123.
• [17]Vandenberg P, Kern A, Ries A, Luckenbill-Edds L, Mann K, Kuhn K: Characterization of a type IV collagen major cell binding site with affinity to the alpha 1 beta 1 and the alpha 2 beta 1 integrins. J Cell Biol 1991, 113:1475-1483.
• [18]Gower WJ: HPAC, a new human glucocorticoid-sensitive pancreatic ductal adenocarcinoma cell line. In Vitro Cell Dev Biol 1994, 30A:151-161.
• [19]Schoumacher RA, Ram J, Iannuzzi MC, Bradbury NA, Wallace RW, Hon CT, Kelly DR, Schmid SM, Gelder FB, Rado TA: A cystic fibrosis pancreatic adenocarcinoma cell line. Proc Natl Acad Sci USA 1990, 87:4012-4016.
• [20]Hamano Y, Zeisberg M, Sugimoto H, Lively JC, Maeshima Y, Yang C, Hynes RO, Werb Z, Sudhakar A, Kalluri R: Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. Cancer Cell 2003, 3:589-601.
• [21]Johansson C, Butkowski R, Wieslander J: Characterization of monoclonal antibodies to the globular domain of collagen IV. Connect Tissue Res 1991, 25:229-241.
• [22]Vindelov LL, Christensen IJ, Nissen NI: A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983, 3:323-327.
• [23]Eble JA, Golbik R, Mann K, Kuhn K: The alpha 1 beta 1 integrin recognition site of the basement membrane collagen molecule [alpha 1(IV)]2 alpha 2(IV). EMBO J 1993, 12:4795-4802.
• [24]Hynes RO: Integrins: bidirectional, allosteric signaling machines. Cell 2002, 110:673-687.
• [25]Huveneers S, Truong H, Danen HJ: Integrins: signaling, disease, and therapy. Int J Radiat Biol 2007, 83:743-751.